Site Map
HOME
- About The “New” Prostate Cancer InfoLink
- The “New” Prostate Cancer InfoLink News Blog
- The “New” Prostate Cancer InfoLink Social Network
- Site map
- Copyright
RISK AND PREVENTION
- What is prostate cancer?
- Who is at risk for prostate cancer?
- Are all cases of prostate cancer equal in risk?
- The PCPT prostate cancer risk calculator
- The Sunnybrook prostate cancer risk calculator
- PSA as a long-term marker for risk
- Prevention: an introduction
- Important articles on prostate cancer prevention
DIAGNOSIS
- For newly diagnosed patients …
- Prostate cancer screening and early detection (and video presentation)
- Signs and symptoms of prostate cancer
- Digital rectal examination or DRE
- Prostate specific antigen testing
- Diagnosis: an introduction
- Prostate biopsy: how it’s done and what’s involved
- The biopsy results: how to read them and what they mean
- What on Earth is PIN?
- That’s not what ASAP stands for! Is it?
- Other important tests
- The prostatic acid phosphatase or PAP test
- MRI, CT, and other imaging tests
- Bone scans
- Evolving tests for new markers
- The spouse/partner’ roles and perspectives
- Important articles on prostate cancer diagnosis
MANAGEMENT
- In the beginning …
- Staging and grading
- Treatment: the absolute basics
- First-line treatments for early stage (localized) disease
- What! You mean I’m going to have to CHOOSE?
- Comparative data on the various options for treatment of early stage (localized) prostate cancer
- Active surveillance and watchful waiting
- Established surgical treatments
- Established radiotherapeutic treatments
- External beam radiation therapy (EBRT)
- Radioactive seed implantation (brachytherapy)
- Less well established treatments
- Cryotherapy
- High intensity focused ultrasound (HIFU)
- Focal therapy: a future possibility?
- Side effects and complications of first-line therapy: an overview
- Erectile dysfunction (risk, natural history, and management)
- Urinary incontinence
- Painful defecation
-
When first-line treatment fails for early stage disease
-
Active surveillance (watchful waiting)
-
The role of salvage surgery
-
The role of radiation therapy
-
The role of hormone therapy
-
Investigational therapies
-
- First-line treatment for non-localized disease
- Active surveillance/watchful waiting
- The role of surgery (surgical debulking)
- External beam radiotherapy
- Hormonal therapies
- Investigational therapies
-
Treatment for advanced (non-metastatic) disease
- Hormonal therapies
- Investigational therapies
-
- Active surveillance (watchful waiting)
- Hormonal therapies
- Investigational therapies
- The treatment of hormone-refractory disease
- Anti-androgen withdrawal
- Chemotherapy
- Palliative treatment in late-stage disease
- Management of severe bone pain
- Management of fractures and other complications
- Exercise, wellness, and response to prostate cancer therapy
- Monitoring treatment: an overview
- The role of PSA tests
- The role of bone scans
- The roles of other tests
- Alternative and complementary medicines
- Side effects and complications of hormonal therapies
- Gynecomastia (swelling and tenderness of the breast)
- Bone loss
- Hot flashes
- Mood changes and depression
- Living with prostate cancer
- When curative therapy fails
- The spouse or partner’s perspective
- The importance of state of mind
- Important articles on the management of prostate cancer
ASK QUESTIONS
TIPS AND TOOLS
- What cancer cannot do
- Major US-based prostate cancer web sites and organizations
- Non-US-based prostate cancer web sites and organizations
- Views from the “other side”: personal reflections about prostate cancer from two urological oncologists
- Tips
- The “top 10″ facts you need to know
- Finding the prostate cancer specialist who is right for YOU
- How to pick a prostate cancer surgeon (by Arnon Krongrad, MD)
- How to select your brachytherapist (by Michael F. Sarosdy, MD)
- How to pick an external beam radiation oncologist
- How to pick a medical oncologist
- Minimally invasive surgery: an overview
- Tools
- Prognostic tools
- Finding out about clinical trials